Frederick Oliver Cope
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$4.5MFederal grants as PI8 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
8 awards · $4.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 14, 2017 | NIH | SBIR Phase II CD206 Targeted Therapy for Kaposi Sarcoma and Tumor Associated Macrophages | $940K | Navidea Biopharmaceuticals, Inc. |
| Aug 9, 2017 | NIH | SBIR Phase II 99mTc-Tilmanocept for Targeting Rheumatoid Arthritis (RA)-Driving Macrophages | $374K | Navidea Biopharmaceuticals, Inc. |
| Sep 1, 2016 | NIH | SBIR Phase II CC49/RIGS, a diagnostic radiopharmaceutical monoclonal antibody, for enhanced liv | $688K | Navidea Biopharmaceuticals, Inc. |
| Aug 30, 2016 | NIH | SBIR Phase II Receptor Mediated SPECT Imaging Of Kaposi Sarcoma With 99mTc-Tilmanocept | $633K | Navidea Biopharmaceuticals, Inc. |
| Jul 26, 2016 | NIH | SBIR Phase II 99mTc-Tilmanocept for Targeting Rheumatoid Arthritis (RA)-Driving Macrophages | $1.1M | Navidea Biopharmaceuticals, Inc. |
| May 25, 2016 | NIH | SBIR Phase II CD206 Targeted Therapy for Kaposi Sarcoma and Tumor Associated Macrophages | $232K | Navidea Biopharmaceuticals, Inc. |
| Aug 27, 2015 | NIH | SBIR Phase II Receptor Mediated SPECT Imaging Of Kaposi Sarcoma With 99mTc-Tilmanocept | $300K | Navidea Biopharmaceuticals, Inc. |
| Jul 3, 2015 | NIH | SBIR Phase II 99mTc-Tilmanocept for Targeting Rheumatoid Arthritis (RA)-Driving Macrophages | $225K | Navidea Biopharmaceuticals, Inc. |
Peer ranks
Federal funding#345
Awards as PI#216
Patents#505
Companies
- Navidea Biopharmaceuticals, Inc.Linked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.